Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 11, 2011, Pages 1244-1249

  Fujimura Kiyono, Chieko ^a   Kimura, Fumiharu ^a   Ishida, Simon ^a   Nakajima, Hideto ^a   Hosokawa, Takafumi ^a   Sugino, Masakazu ^a   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALS FUNCTIONAL RATING SCALE; AMYOTROPHIC LATERAL SCLEROSIS; ARM; ARTICLE; BULBAR PARALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MOTONEURON; MOTOR PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RESPIRATORY TRACT DISEASE; SURVIVAL; SURVIVAL RATE;

AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053636587     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-300141     Document Type: Article

References (40)

1. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118:707-19.
2. Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995;132:207-15.
3. Kimura F, Shinoda K, Fujiwara S, et al. The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000 (in Japanese). Rinsho Shinkeigaku 2003;43:385-91. (Pubitemid 37295626)
4. Nalini A, Thennarasu K, Gourie-Devi M, et al. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci 2008;272:60-70.
5. Turner MR, Brockington A, Scaber J, et al. Pattern of spread and prognosis in lower limb-onset ALS. Amyotroph Lateral Scler 2010;11:369-73.
6. Kimura F, Fujimura C, Ishida S, et al. A study of bulbar, upper extremity, and lower extremity motor function preservation at the time that respiratory symptoms appear in ALS (in Japanese). Rinsho Shinkeigaku 2007;47:140-6. (Pubitemid 46804590)
7. Houseman G, Kelley M. Early respiratory insufficiency in the ALS patient: a case study. J Neurosci Nurs 2005;37:216-18.
8. Gil J, Preux PM, Alioum A, et al. Disease progression and survival in ALS: first multi-state model approach. Amyotroph Lateral Scler 2007;8:224-9. (Pubitemid 47190226)
9. Mateen FJ, Carone M, Sorenson EJ. Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004. J Neurol Neurosurg Psychiatry 2010;81:1144-6.
10. Eisen A, Schulzer M, MacNeil M, et al. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve 1993;16:27-32. (Pubitemid 23014301)
11. World Federation of Neurology Research Group on neuromuscular diseases. Subcommittee on motor neuron diseases "El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis". J Neurol Sci 1994;124:96-107.
12. Czaplinski A, Yen AA, Simpson EP, et al. Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 2006;34:702-8. (Pubitemid 44883081)
13. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21. (Pubitemid 29502501)
14. Kaufmann P, Levy G, Thompson JL, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005;64:38-43. (Pubitemid 40082934)
15. Tysnes OB, Vollset SE, Larsen JP, et al. Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology 1994;13:226-35. (Pubitemid 24229138)
16. Del Aguila MA, Longstreth WT Jr, McGuire V, et al. Prognosis in amyotrophic lateral sclerosis. A population-based study. Neurology 2003;60:813-19. (Pubitemid 36297366)
17. Hardiman O. Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis. J Neurol 2000;247:245-51. (Pubitemid 30223959)
18. Pinto S, Pinto A, De Carvalho M. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients? Eura Medicophys 2007;43:505-9.
19. Lou JS, Moore D, Gordon PH, et al. Correlates of quality of life in ALS: lessons from the minocycline study. Amyotroph Lateral Scler 2010;11:116-21.
20. Marin B, Desport JC, Kajeu P, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2011;82:628-34.
21. Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007;68:1571-5. (Pubitemid 46717980)
22. Pinto S, Geraldes R, Vaz N, et al. Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis. longitudinal study. Clin Neurophysiol 2009;120:2082-5.
23. Münch C, O'Brien J, Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A 2011;108:3548-53.
24. Braak H, Tredici DK. Invited article: Nervous system pathology in sporadic Parkinson disease. Neurology 2008;70:1916-25. (Pubitemid 351684646)
25. Chio A, Mora G, Leone M, et al; Piemonte and Valle d'Aosta Register for ALS (PARALS). Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 2002;59:99-103. (Pubitemid 34742801)
26. Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265-7. (Pubitemid 43970171)
27. Kollewe K, Mauss U, Krampfl K, et al. ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci 2008;275:69-73.
28. Wijesekera LC, Mathers S, Talman P, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 2009;72:1087-94.
29. Brooks BR. Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology 1996;47(Suppl 2):S71-81.
30. Ravits J, Laurie P, Fan Y, et al. Implications of ALS focality: rostralecaudal distribution of lower motor neuron loss postmortem. Neurology 2007;68:1576-82. (Pubitemid 46717981)
31. Desport JC, Preux PM, Truong TC, et al. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999;53:1059-63. (Pubitemid 29442123)
32. Desport JC, Marin B, Funalot B, et al. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008;9:273-8.
33. Limousin N, Blasco H, Corcia P, et al. Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS. J Neurol Sci 2010;297:36-9.
34. Zoccolella S, Beghi E, Palagano G, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2008;79:33-7.
35. Mitsumoto H, Davidson M, Moore D, et al ALS CARE Study Group. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:177-85. (Pubitemid 37184888)
36. Traynor BJ, Alexander M, Corr B, et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003;74:1258-61.
37. Similowski T, Attali V, Bensimon G, et al. Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis. Eur Respir J 2000;15:332-7. (Pubitemid 30085962)
38. Sathyaprabha TN, Pradhan C, Nalini A, et al. Pulmonary function tests and diaphragmatic compound muscle action potential in patients with sporadic amyotrophic lateral sclerosis. Acta Neurol Scand 2010;121:400-5.
39. Traynor BJ, Zhang H, Shefner JM, et al. Functional outcome measures as clinical trial endpoints in ALS. Neurology 2004;63:1933-5. (Pubitemid 39532394)
40. Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry 2006;77:390-2.